Laidlaw Stock Recommendations and Price Targets

This is a list of recent ratings by Laidlaw.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
9/6/2022
NLSP
NLS Pharmaceutics
Initiated Coverage$1.00 $6.00BuyLow
6/23/2022
FSTX
F-star Therapeutics
Downgrade$5.00Buy ➝ HoldLow
6/2/2022
EVFM
Evofem Biosciences
Initiated Coverage$0.00 $3.50BuyHigh
1/20/2022
CING
Cingulate
Initiated Coverage$1.00 $8.50BuyHigh
9/13/2021
VINC
Vincerx Pharma
Initiated Coverage$1.00 $30.00BuyLow
5/10/2021
LIFE
aTyr Pharma
Initiated Coverage$3.00 $18.00BuyHigh
3/24/2021
FSTX
F-star Therapeutics
Initiated Coverage$5.00 $32.00BuyHigh
3/1/2021
ATNX
Athenex
Lower Price Target$0.00$38.00 ➝ $13.00BuyMedium
8/24/2020
ONTX
Onconova Therapeutics
Downgrade$1.00Buy ➝ HoldHigh
8/9/2020
AFMD
Affimed
Reiterated Rating$2.00 $10.00Market Perform ➝ BuyMedium
7/29/2020
CRIS
Curis
Initiated Coverage$1.00 $5.00BuyMedium
6/5/2020
SLNO
Soleno Therapeutics
Reiterated Rating$2.00 $150.00BuyLow
6/1/2020
DCTH
Delcath Systems
Initiated Coverage$3.00 $19.00BuyHigh
5/26/2020
ALDX
Aldeyra Therapeutics
Reiterated Rating$5.00 $30.00BuyLow
12/23/2019
SLNO
Soleno Therapeutics
Initiated Coverage$2.00BuyHigh
11/4/2019
EYPT
EyePoint Pharmaceuticals
Initiated Coverage$8.00 $500.00BuyHigh